ALB and central nervous system cancer: Lin et al. (2016) developed BBB-penetrating albumin NPs for the dual-drug delivery of paclitaxel and fenretinide, and these albumin NPs exhibited improved treatment outcomes in glioma models with reduced toxic side effects [144].